Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Gastric Cancer

Free Subscription 16.03.2026 1 BMC Gastroenterol 1 Clin Cancer Res 1 Clin Res Hepatol Gastroenterol 1 Dig Dis Sci 5 Eur J Surg Oncol 1 Gut 1 Hum Pathol 2 Int J Cancer 1 Int J Oncol 2 J Cancer Res Clin Oncol 2 J Clin Oncol 2 J Gastroenterol Hepatol 1 J Surg Oncol 1 N Engl J Med 2 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. ALIYEV A, Ibrahimli A, Kok JHH, Samadov E, et al
   The role of GP73 in predicting overall survival and chemotherapy response in locally advanced gastric cancer: a retrospective cohort study.
   BMC Gastroenterol. 2026 Mar 5. doi: 10.1186/s12876-026-04713.
   PubMed        
   
   

   
   Clin Cancer Res

2. CASAK SJ, Zhang Y, Song C, Mishra-Kalyani PS, et al
   FDA Approval Summary: Pembrolizumab for the Treatment of HER2-Positive Gastric Cancer.
   Clin Cancer Res. 2026 Mar 6:10.1158/1078-0432.CCR-25-3726.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

3. BOISTEAU E, Landrieux A, Gnep K, Ahrweiller F, et al
   Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancer.
   Clin Res Hepatol Gastroenterol. 2026 Mar 10:102803.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

4. XU X, Chen Y, Zhang L, Pan P, et al
   WISP2 Overexpression Is Associated with Reduced Vasculogenic Mimicry and Epithelial-Mesenchymal Transition in Gastric Cancer.
   Dig Dis Sci. 2026 Mar 8. doi: 10.1007/s10620-026-09801.
   PubMed         Abstract available
   
   

   
   Eur J Surg Oncol

5. CASELLA F, Geroin C, Meloni F, Bencivenga M, et al
   Enhanced recovery after surgery for gastric cancer with HIPEC: feasibility and outcomes in a complex setting.
   Eur J Surg Oncol. 2026;52:111483.
   PubMed         Abstract available
   
   
6. RI M, Ohashi M, Hayami M, Irino T, et al
   Unexpected proximal tumor extension as a predictor of poor survival after distal gastrectomy for locally advanced gastric cancer.
   Eur J Surg Oncol. 2026;52:111513.
   PubMed         Abstract available
   
   
7. LIU C, Huang H, Liu J, Cao C, et al
   Effect of whole-course nutrition management on skeletal muscle mass in patients with gastric cancer undergoing neoadjuvant treatment.
   Eur J Surg Oncol. 2026;52:111463.
   PubMed         Abstract available
   
   
8. VISSERS PAJ, Luijten JCHBM, Lemmens VEPP, van Laarhoven HWM, et al
   The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
   Eur J Surg Oncol. 2023;49:107019.
   PubMed         Abstract available
   
   
9. ELSHAER AM, Wijeyaratne M, Higgs SM, Hornby ST, et al
   Peri-operative chemotherapy versus preoperative chemoradiotherapy in treatment of gastro-oesophageal junctional adenocarcinomas: A 10-year cohort study.
   Eur J Surg Oncol. 2023;49:107016.
   PubMed         Abstract available
   
   

   
   Gut

10. LEUNG WK, Ang TL, Shah S, Cheung KS, et al
    Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions.
    Gut. 2025 Oct 7:gutjnl-2025-335823. doi: 10.1136/gutjnl-2025-335823.
    PubMed         Abstract available
    
    

    
    Hum Pathol

11. NAM GH, Tan HM, Quddus MR, Dong J, et al
    Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma: Diagnostic Criteria, Differential Diagnosis, and Molecular Insights.
    Hum Pathol. 2025 Dec 29:106031. doi: 10.1016/j.humpath.2025.106031.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. DING S, Huang H, Cao C, Liu C, et al
    Efficacy and safety of neoadjuvant apatinib plus PD-1 inhibitor with SOX for locally advanced gastric cancer: A multicenter, retrospective cohort study.
    Int J Cancer. 2026 Mar 13. doi: 10.1002/ijc.70430.
    PubMed         Abstract available
    
    
13. WEI C, Wei H, Chen X, Zheng Z, et al
    Patterns of recurrence after curative resection and adjuvant chemotherapy in gastric and gastroesophageal junction cancer.
    Int J Cancer. 2026;158:2240-2252.
    PubMed         Abstract available
    
    

    
    Int J Oncol

14. PENG S, Chen Y, Wu J, Huang X, et al
    RNA?binding protein DAZAP1 promotes gastric cancer metastasis by enhancing NOTCH1 and JAG1 mRNA stability.
    Int J Oncol. 2026;68:50.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

15. LIU DHW, Grabsch HI, Gloor B, Langer R, et al
    Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases.
    J Cancer Res Clin Oncol. 2023;149:13345-13352.
    PubMed         Abstract available
    
    
16. PAPE M, Vissers PAJ, Kato K, Haj Mohammad N, et al
    A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands.
    J Cancer Res Clin Oncol. 2023;149:13323-13330.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

17. ZHENG G, Zhang X, Zhang J, Zheng Z, et al
    Immune Checkpoint Blockade in Deficient Mismatch Repair/Microsatellite Instability-High Gastric Cancer: Solid Evidence or Premature Extrapolation?
    J Clin Oncol. 2026 Mar 12:JCO2502546. doi: 10.1200/JCO-25-02546.
    PubMed        
    
    
18. LEONE AG, Raimondi A, Pietrantonio F
    Reply to: Immune Checkpoint Blockade in Deficient Mismatch Repair/Microsatellite Instability-High Gastric Cancer: Solid Evidence or Premature Extrapolation?
    J Clin Oncol. 2026 Mar 12:JCO2503022. doi: 10.1200/JCO-25-03022.
    PubMed        
    
    

    
    J Gastroenterol Hepatol

19. TSAO C, Ma Y, Wang F, Yu H, et al
    IKZF3 Promotes Gastric cancer Progression and Oxaliplatin Resistance via PI3K/AKT/mTOR Activation.
    J Gastroenterol Hepatol. 2026 Mar 12. doi: 10.1111/jgh.70331.
    PubMed         Abstract available
    
    
20. HUA T, Zhai L
    A Critical Appraisal of a Ferroptosis-Base Prediction Model for Neoadjuvant Chemotherapy in Gastric Cancer.
    J Gastroenterol Hepatol. 2026 Mar 11. doi: 10.1111/jgh.70250.
    PubMed        
    
    

    
    J Surg Oncol

21. SALEHI O, Somasundar P, Espat NJ, Calvino AS, et al
    The Impact of Institutional Volume of Endoscopic Resection on Early-Stage Gastric Cancer Outcomes.
    J Surg Oncol. 2026 Mar 8. doi: 10.1002/jso.70223.
    PubMed         Abstract available
    
    

    
    N Engl J Med

22. PARK JY, Lee YC, Moayyedi P, Lansdorp-Vogelaar I, et al
    Helicobacter pylori Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report.
    N Engl J Med. 2026;394:1131-1137.
    PubMed        
    
    

    
    Oncol Rep

23. WANG TA, Zhang XD, Guo XY, Xian SL, et al
    [Corrigendum] 3?Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial?mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
    Oncol Rep. 2026;55:91.
    PubMed         Abstract available
    
    
24. SHI ZY, Ding ZR, Huang YL, Lei YR, et al
    Silencing of SIVA?1 promotes cisplatin resistance in gastric cancer via the Bcl?2/BAX?mediated mitochondria?dependent apoptosis pathway.
    Oncol Rep. 2026;55:95.
    PubMed         Abstract available
    
    

    
    PLoS One

25. HUANG M, Chu J, Yu W, Dou L, et al
    Patient-derived organoids predict chemotherapy response of locally advanced gastric cancer.
    PLoS One. 2026;21:e0339416.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum